Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2011 Winter;23(1):56-62.
doi: 10.1176/jnp.23.1.jnp56.

Binge eating in Parkinson's disease: prevalence, correlates and the contribution of deep brain stimulation

Laura B Zahodne  1 , Frandy Susatia, Dawn Bowers, Tiara L Ong, Charles E Jacobson 4th, Michael S Okun, Ramon L Rodriguez, Irene A Malaty, Kelly D Foote, Hubert H Fernandez
Affiliations
Comparative Study

Binge eating in Parkinson's disease: prevalence, correlates and the contribution of deep brain stimulation

Laura B Zahodne et al. J Neuropsychiatry Clin Neurosci. 2011 Winter.

Abstract

Of 96 Parkinson's disease patients surveyed at the University of Florida Movement Disorders Center, one (1%) met diagnostic criteria for binge-eating disorder. Eight (8.3%) exhibited subthreshold binge eating. Psychometric criteria classified problem gambling in 17.8%, hoarding in 8.3%, compulsive buying in 11.5%, hypersexuality in 1.0%, and mania in 1.0% of patients. More overeaters met psychometric criteria for at least one additional impulse-control disorder (67% versus 29%). No more overeaters than non-overeaters were taking a dopamine agonist (44% versus 41%). More overeaters had a history of subthalamic deep brain stimulation (DBS; 44% versus 14%). History of DBS was the only independent predictor of overeating.

PubMed Disclaimer

References

    1. Simuni T, Sethi K. Nonmotor manifestations of Parkinson’s disease. Ann Neurol. 2008;64:S65–S80. - PubMed
    1. Wolters E, van der Werf YD, van den Heuvel OA. Parkinson’s disease-related disorders in the impulsive-compulsive spectrum. J Neurol. 2008;255:48–56. - PubMed
    1. Evans AH, Lees AJ. Dopamine dysregulation syndrome in Parkinson’s disease. Curr Opin Neurol. 2004;17:393–398. - PubMed
    1. Weintraub D. Dopamine and impulse control disorders in Parkinson’s disease. Ann Neurol. 2008;64:S93–100. - PMC - PubMed
    1. Weintraub D, Siderowf AD, Potenza MN, et al. Association of dopamine agonist use with impulse control disorders in Parkinson disease. Arch Neurol. 2006;63:969–973. - PMC - PubMed

Publication types

MeSH terms